A B S T R A C T In Hodgkin's disease a possible mechanism for impaired cellular immunity is cell-mediated suppression, defined as the inhibitory interaction between suppressor cells and effector lymphocytes. To test for the presence of suppressor cells in peripheral blood, we have modified the standard, one-way mixed lymphocyte culture by adding mitomycin C-treated mononuclear cells from the responder. Suppression, expressed as a percent of the base-line mixed lymphocyte culture in which these extra cells are not present, results in a reduction of thymidine incorporated in the modified culture (i.e., 100% suppression = no net thymidine incorporation; 0% suppression = identical thymidine incorporation in both the modified and baseline cultuLre).
A B S T R A C T In Hodgkin's disease a possible mechanism for impaired cellular immunity is cell-mediated suppression, defined as the inhibitory interaction between suppressor cells and effector lymphocytes. To test for the presence of suppressor cells in peripheral blood, we have modified the standard, one-way mixed lymphocyte culture by adding mitomycin C-treated mononuclear cells from the responder. Suppression, expressed as a percent of the base-line mixed lymphocyte culture in which these extra cells are not present, results in a reduction of thymidine incorporated in the modified culture (i.e., 100% suppression = no net thymidine incorporation; 0% suppression = identical thymidine incorporation in both the modified and baseline cultuLre).
Suppression was found to be significantly increased in patients with both active Hodgkin's disease (78 ±4.6%) and remission Hodgkin's disease (58±9.3%) compared to normal individuals (21±6.9%) (mean ±+SE). The degree and frequency of suppression were not influenced by disease stage or prior therapy. Cell purification techniques revealed (in 10 patients studied) the suppressor cell to be a monocyte in 6, and a thymus-derived lymphocyte in 4. Possible genetic restriction of the suppressor cell interaction was indicated by a failure of suppressor cells to alter the response of lymphocytes from unrelated individuals, but suppression was obtained with lymphocytes from a histocompatible sibling. Although mononuclear cells from normal individuals suppress less frequently than cells from patients with Hodgkin's disease, normals may demonstrate suppression comparable to that observed in Hodgkin's patients. This finding suggests INTRODUCTION Patients with Hodgkin's disease, both active and in remission, frequenitly have impaired cell-mediated immunitv as demonstrated by anergy to recall skin tests (1) (2) (3) , failure of dinitrochlorobenzene senisitization (4), prolonged skin allograft survival (3, 5) , and impaired immunitv after BCG vaccination (6) . Lymphocyte fuinction in vitro is also impaired as ineastured using mitogeni (phytohemagglutinin, coincainavalin A, and pokeweed mitogen), and antigen responsiveness (1, 2, 7, 8) , as well as stinulatioin and proliferatioin in mixed lymphocyte ctultures (9, 10) . It has been suggested that the reduced cellular immutnity canl be explained by a diminished number of thymus-derived lymphocytes (T lymphocyte), and both lymphopeniia and diminished percentages of T lyimphocytes have been described in some Hodgkin's disease patients (11, 12) . However, these findings correlate poorly with other parameters of immunite function (1) . Recently, Fuks et al. have demonstrated a serum f:actor in Hodgkin's disease that interferes with the formationi of' sheep erythrocyte rosettes (E rosettes)' by T lymphocytes, b)ut its clinical significance remains to be established (13) .
Another possible mechanisimi for impaired immnunity in Hodgkin's disease involves cell-mediated suppressioni. Cells that mediate suppressioni exert an inhibitory effect on the fuinctioni of effector lymplhocytes. Suppressor cells have been characterized in a variety of animal models and have beeni shown to be responisible for impaired humoral immunity in somile patients wvith common variable hypogammaglobulinemiiia (14, 15) and multiple myeloi-na (16 tion. In Hodgkin's disease mononuclear cells from patients of advanced stage may contain suppressor cells that are responsible for both poor phytohemagglutinininduced proliferation (17) and impaired stimulation in mixed lymphocyte culture (10) .
We have examined the possibility that increased suppressor cell activity may be more common than presently appreciated in Hodgkin's disease patients. With a modification of the standard one-way mixed lymphocyte culture, we have found increased suppression of lymphocyte proliferation, mediated by either T lymphocytes or monocytes, in the majority of patients with active and remission Hodgkin's disease. This suppressive effect, which can occur to a lesser degree in normal individuals, appears genetically restricted to autologous, and to histocompatible, cellular interactions.
METHODS
Subjects. The study group consists of 23 unselected, consecutively studied patients with Hodgkin's disease (13 male, 10 female), age ranging from 18 to 75 yr, seen at Barnes Hospital, St. Louis, Mo. between 1976 and 1977. 14 patients had active disease; 9 of these were previously untreated. The remaining five patients with active disease all had prior treatment with radiation therapy, and all but one with prior chemotherapy. Nine patients with Hodgkin's disease in clinical remission of at least 6 mo also were studied. All patients were off therapy for a minimum of 6 wk before study.
Histologic classification of Hodgkin's disease was made according to the Rye Conferences modification (18) . Patients were staged in accord with the recommendations of the Ann Arbor Conference (19) .
The control population consists of 19 normal, healthy volunteers (8 male, 11 female) with an age ranging from 16 to 45 yr.
Mononuclear cell preparation. Mononuclear cells were prepared by density sedimentation of heparinized blood over Ficoll (Sigma Chemical Co., St. Louis, Mo.) sodium diatrizoate (Hypaque sodium, 50%, Winthrop Laboratories, New York), by a minor modification of B6yum's technique (20) , and thrice washed in Hanks' balanced salt solution (HBSS, Grand Island Biological Co., Grand Island, N. Y.) plus 1% (vol:vol) saltpoor human serum albumin (HBSS/albumin, Parke, Davis & Co., Detroit, Mich.).
Mononuclear cells were resuspended in tissue culture media consisting of 78 ml of Medium 199, 1 ml L-glutamine (200 mM), 1 ml penicillin (1,000 U)/streptomycin (10,000 ,ug) (all obtained from Grand Island Biological Co.), and 20 ml human plasma from normal individuals (TC 199/20% plasma). Proliferation of cells designated for subsequent use as either stimulators or suppressors in mixed lymphocyte culture was prevented by treatment with mitomycin C (Sigma Chemical Co.). The cells were incubated with mitomycin C (50,tg/ml) for 30 min at 370C and then washed twice in HBSS/albumin. Alternatively, when mononuclear cell recovery was small, proliferation was inhibited by irradiation with 2,000 rads from a 131CS source (Gamma Cell-20 Small Animal Irradiator, Atomic Energy of Canada, Ltd., Ottawa, Canada), before culturing.
Removal of adherent cells. Nylon wool filters were made with a modification of the method of Mendelsohn et al. (21) . Mononuclear cells suspended in Medium 199/10% heat-inactivated fetal calf serum (Grand Island Biological Co.), were incubated on the filters at 370C for 30 min. Nonadherent cells were eluted from the filters with Medium 199/10% FCS warmed to 37°C, washed twice in HBSS/albumin, and resuspended in TC 199/20% plasma. The nonadherent population contained fewer than 1% monocytes as judged by microscopic examination of blood films stained supravitally with Janus green and neutral red (22) .
Removal of phagocytic cells with carbonyl iron. Phagocytic cells were removed from whole-blood ali(luots with carbonyl iron (GAF Corporation, New York) as described by Lohrmann et al. (23) . 80% of'the monocytes were removed by this techniqlue as determined microscopically (22) .
Separation of E-rosetting cells. The method f'or rosette separation was a modification of the procedure described by Lohrmann et al. (23) . 2.5 x 106 mononuclear cells (either unmanipulated, or previously treated with carbonyl iron) were mixed with 5 x 107 neuraminidase-(Vibrio cholerae neuraminidase, 50 U/ml, Grand Island Biological Co.) treated sheep erythrocytes (Flow Laboratories, Rockville, Md.) and 0.25 ml of fetal calf' serum, centrifuged, and incubated at room temperature for 15 min. The cell pellet was gently resuspended to avoid disrupting rosettes, and the light, nonrosetting cells were separated from the heavier, T-lymphocyte rosettes by centrifugation over Ficoll-Hypaque.
80% of the E-rosetting cells were depleted from the nonrosetting fraction when retested with fresh neuraminidasetreated sheep erythrocytes. Both layers were retained, washed, and contaminating sheep erythrocytes were lysed by incubation in human plasma (which contains naturally occurring antibodies hemolytic for sheep erythrocytes) at 370C x 30 min. These cells were twice washed in HBSS/albumin, and resuspended in TC 199/20% plasma. Approximately 50% of the E-rosetting cells present in the initial mononuclear cell suspension were recovered.
Cell cultures. Base-line, one-way, mixed lymphocyte cultures were established by adding 2 x 105 responder cells from Hodgkin's disease patients or normal controls (2A) and 4 x 105 fresh mitomycin C-treated allogeneic stimulator cells from a single normal donor (4 Bm) in TC 199/20% plasma. For suppressor cultures, 16 x 105 additional cells autologous to the responder (16Am), and treated with mitomycin C, were added. Approximately 80% of the cells initially present were recovered after treatment with mitomycin C. Each experiment included unstimulated cultures, in which allogeneic cells were replaced with the same number of mitomycin C-treated autologous mononuclear cells (i.e., 2A + 4Am). As an additional control, allogeneic combinations of mitomycin Ctreated cells were cultured to insure inhibition of proliferation by the treatment (i.e., 4Am + 4Bm). All cultures were performed in triplicate in 2 ml in 12 x 77-mm polypropylene tubes (Falcon Plastics, Div. BioQuest, Oxnard, Calif.) and were incubated at 37°C in a humid environment in 5% CO2.
At 120 h, 2 ,uCi of [methyl-3H]thymidine (6.7 Ci/mmol, New England Nuclear, Boston, Mass.) were added and cultures were terminated 18 h later by addition of cold 5% TCA. Table  I . In addition, net thymidine incorporation for the baseline and suppressor cultures are tabulated for the patients and for the 19 normal donors. Fig. 1 illustrates the degree of mixed lymphocyte culture suppression produced by mononuclear cells from patients with active Hodgkin's disease compared to remission Hodgkin's disease and normal controls. The mean percent suppression (+SE) for the three groups are (a) normals, 21%±6.9%; (b) active Hodgkin's disease, 78%+4.6%; and (c) remission Hodgkin's disease, 58%±9.3%. The difference between patients with active or remission Hodgkin's disease and normal controls is statistically significant (P < 0.01 and P < 0.05, respectively). In Hodgkin's disease, although it appears that greater suppression is achieved with mononuclear cells from patients having active disease, the difference is not statistically significant.
Patients previously treated with chemotherapy and radiotherapy showed reduced reactivity in all cultures (Table I) . However, prior treatment did not alter the degree of suppression as compared to untreated patienits. Having demonstrated increased suppressor activity in Hodgkin's disease patients, we next sought to clarify the mechanism of suppression. Because the suppressor cultures were at a higher cell density than the baseline cultures, it was necessary to determine whether changes in cell density alone alter the proliferative response. Dose-response curves in 12 normal donors were performed comparing the proliferative response of 2 x 105 mononuclear cells when stimulated with 4, 16, and 20 x 105 mitomycin-treated allogeneic cells (Fig. 2) , corresponding to the cell density of the standard mixed lymphocyte culture and the suppressor cultures. The mean thymidine incorporation (±+-SE) in counts per minute is 36,696+ 11,002, 33,027+8,058, and 58,884-+23,046, respectively. No suppression in proliferation was noted at the higher cell densities.
Effect of "suppressor" cells on normal allogeneic responder lymphocytes in mixed lymphocyte culture. In the foregoing studies, it was demonstrated that mitomycin C-treated mononuclear cells from patients with active Hodgkin's disease inhibit the proliferative capacity of their own lymphocytes. To determine their effect on normal, allogeneic lymphocytes, mitomycin C-treated mononuclear cells from patients with Hodgkin's disease were added to normal responding cells in mixed lymphocyte culture at two concentrations and percent suppression was calculated (see Methods). Effect of altering suppressor cell number. In one patient, the effect on proliferation of increasing numbers of "suppressor" cells was determined, keeping both the responder and stimulator concentrations constant. A nearly linear fall in [3H]thymidine incorporation occurred as the concentration of "suppressor" cells was increased from 0 to 16 x 105 cells/culture. Effect of altering culture incubation time. To exclude the possibility that suppression seen in our 6-day, mixed lymphocyte culture was simply because of alteration in the kinetics of the mixed lymphocyte culture, without a decline in peak reactivity, cultures were terminated on days 5, 6, and 7. Suppression was similar over the 3-day period even though thymidine incorporation increased with increased culture time.
Identification ofsuppressor cells. Mononuclear cell suspensions from 10 patients were fractionated to identify the suppressor cell type. Evidence for lymphocyte-mediated suppression was noted in four patients. In two ofthese, mononuclear cell suspensions depleted of >99% monocytes by nylon wool filtration showed no reduction in suppression, indicating the presence of suppressor lymphocytes (Table III, pts. 9 and 12). Additional evidence for lymphocyte-mediated suppression was obtained by E-rosette separation, without prior monocyte depletion. Removal of E-rosetting T lymphocytes from the mononuclear cell suspension resulted in a loss of suppressor activity in two patients (Fig. 4) . In one of these, the T-lymphocyte enriched fraction, after lysis of sheep erythrocytes, demonstrated enhanced suppressive ability. This fraction was not tested in the other patient.
In six patients, two studied by rosette separation, three by carbonyl iron-induced phagocyte depletion, and one with both techniques, the evidence suggested monocyte-mediated suppression. In three studies with rosette separation, the suppressor cell remained in 
DISCUSSION
The existence of suppressor cells and their role in modifying the immune response has been appreciated only recently. Gershon, who coined the term "suppressor T cell," has reviewed many of their known interactions (25) . Murine models have provided the principal framework for studying these interactions, and both thymus-derived lymphocytes and monocytes have shown suppressor functions (26) (27) (28) (29) (30) In the present study we describe a modified mixed lymphocyte culture technique which can be used to demonstrate active cell-mediated suppression. With this technique we have demonstrated the presence of increased suppressor activity in the majority of patients with Hodgkin's disease compared to normal controls. Suppressor activity could not be correlated with either disease stage or prior treatment of the patients. Evidence has been presented to show that the reduction in lymphocyte proliferation observed in suppressor cultures is not due simply to the increased cell density or depletion of nutritional factors, and is linearly related to the number of suppressor mononuclear cells present.
A recent study by Goodwin and his associates (31) indicates that suppression of the response to phytohemagglutinin may result from increased production of prostaglandin E2 by mononuclear cells from patients with Hodgkin's disease, and can be prevented by adding indomethacin to the cultures. The effect of indo-methacin on mixed lymphocyte culture suppression remains to be determined. However (10) . In the two patients we studied by both techniques, depletion of' phagocytic cells and depletion of adherent cells produced the same results. Other investigators also have described a phagocytic suppressor cell in Hodgkin's disease patients (17) . These differing results may be explained by differences in the patient populations under study as well as dif'ferent methods of determining suppression. An initeresting feature of T-cell-mediated suppression in murine systems is the apparent restriction of suppression to cells which share I-region specificities (27) 
